India’s drug regulator, the Central Drugs Standard Control Organisation (CDSCO), has said pharmaceutical firms failed to comply with the rule requiring every batch of pharmaceutical ingredients to be tested. This comes after 20 children under the age of five reportedly died in Madhya Pradesh from consuming toxic cough syrups.

Meanwhile, the World Health Organisation (WHO) said it has sought clarification from the Indian government on whether Coldrif cough syrup — the product linked to the fatalities — has been exported to other countries. The WHO added that it will assess the need to issue a Global Medical Products Alert on Coldrif once it receives official confirmation from the government.

Plant sealed, MP SIT visits pharma unit, office

A pharma unit producing a now banned cough syrup

See Full Page